Articles

In a new age of personalised cancer therapy, is patent law in Europe still fit for purpose?

In the last week it has been announced that the NHS has struck a deal with Novartis to offer their ground-breaking new CAR-T therapy, Kymriah®, to paediatric patients with B cell acute lymphoblastic leukaemia. This is a significant development and means that some patients will now have access to this...

Read more

Patent licensing trends in the UK pharmaceutical sector

2018 was billed by some in the industry as the year of pharma M&As. However, as of September, we still haven’t seen the acquisition values that were expected following a rather barren 2017. What we have seen are record high patent licensing deals. If your company is built on a...

Read more

UK’s top business schools cannot neglect the importance of intellectual property

Intellectual property is passed around leadership teams like a hot potato with no one wanting to take ultimate responsibility, despite it being essential. Because of this, Peter Finnie from Gill Jennings & Every believes business schools must do more to integrate IP into the curriculum. The value of a business extends well...

Read more

Get your patents IN: India – the next hotbed of fintech innovation

With e-commerce making up just 4% of the retail market, most of the population still yet to be exposed to digital disruption, and a start-up ecosystem only a decade old – India might seem like an unlikely location for fintech innovation. Yet, in May, Indian company Flipkart became the world’s...

Read more

Is there a missing link in your IP strategy?

Bearings manufacturer CeramicSpeed caused quite a stir at the recent Eurobike trade shown in Germany with their chainless, drive-shaft based drivetrain. In the last few years alone, the cycling industry has seen many innovations, including electronic gears, more gears, fewer gears, disc brakes, power meter developments, e-bikes, tubeless tyre technology...

Read more